glp 1 for iih Idiopathic Intracranial Hypertension and the Challenge of Weight Loss GLP-1's and IIH : r/iih

Currey, L., Thor, S

Kyowa Kirin ends the Amgen partnership and regains full rights to rocatinlimab, targeting solo filings in H1 2026

Wait and Withdraw: Once the syringe is empty, wait for about 5-10 seconds before withdrawing the needle

Governments and private organizations are increasingly investing in chronic disease management programs, which indirectly boost demand

In a head-to-head open-label trial reported in February 2026, average weight loss at 84 weeks favored tirzepatide, and the sponsor noted CagriSema did not meet its prespecified non-inferiority target against tirzepatide

Tumors were harvested 4 days post final treatment and subjected to flow cytometric analysis for quantifying ( a ) inhibitory CD8 + T, ( b ) inhibitory CD4 + T, and ( c ) anti-tumor CD8 + T cell populations, as well as ( d ) macrophages, ( e ) MDSCs, ( f ) dendritic cells, and ( g ) monocytes, according to markers in Tables S3 and S4